Tubeimoside IICAS# 115810-12-3 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 115810-12-3 | SDF | Download SDF |
| PubChem ID | 101130898 | Appearance | Powder |
| Formula | C63H98O30 | M.Wt | 1335.5 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Synonyms | Tubeimoside-B | ||
| Solubility | Soluble in DMSO and methanol; insoluble in water | ||
| SMILES | CC1C2C(C(C(O1)OC3C(C(COC3OC(=O)C45CCC(CC4C6=CCC7C(C6(CC5O)C)(CCC8C7(CC(C(C8(C)CO)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(CO1)OC(=O)CC(CC(=O)O2)(C)O)O)O)O)C)C)(C)C)O)O)O)OC1C(C(C(CO1)O)O)O | ||
| Standard InChIKey | GBWAAJJGXQJTTA-YMYRZEKGSA-N | ||
| Standard InChI | InChI=1S/C63H98O30/c1-25-46-47(89-51-43(77)38(72)29(67)21-82-51)45(79)53(85-25)91-48-39(73)30(68)22-83-54(48)93-56(80)63-14-13-57(2,3)15-27(63)26-9-10-34-59(5)16-28(66)50(60(6,24-65)33(59)11-12-61(34,7)62(26,8)17-35(63)69)92-55-49(42(76)40(74)31(20-64)87-55)90-52-44(78)41(75)32(23-84-52)86-36(70)18-58(4,81)19-37(71)88-46/h9,25,27-35,38-55,64-69,72-79,81H,10-24H2,1-8H3/t25-,27-,28-,29+,30-,31+,32-,33+,34+,35+,38-,39-,40+,41-,42-,43+,44+,45+,46-,47-,48+,49+,50-,51-,52-,53-,54-,55-,58-,59-,60-,61+,62+,63+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Tubeimoside I, tubeimoside II, and tubeimoside III show anti-inflammatory, antitumor, and antitumor-promo ting effects. |
| Targets | Immunology & Inflammation related |
| In vivo | Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects.[Pubmed: 11743898]Acta Pharmacol Sin. 2001 May;22(5):463-8.To study structure-activity relationship of tubeimosides isolated from Bolbostemma paniculatum for their anti-inflammatory, antitumor, and antitumor-promoting effects.
|
Tubeimoside II Dilution Calculator
Tubeimoside II Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.7488 mL | 3.7439 mL | 7.4878 mL | 14.9757 mL | 18.7196 mL |
| 5 mM | 0.1498 mL | 0.7488 mL | 1.4976 mL | 2.9951 mL | 3.7439 mL |
| 10 mM | 0.0749 mL | 0.3744 mL | 0.7488 mL | 1.4976 mL | 1.872 mL |
| 50 mM | 0.015 mL | 0.0749 mL | 0.1498 mL | 0.2995 mL | 0.3744 mL |
| 100 mM | 0.0075 mL | 0.0374 mL | 0.0749 mL | 0.1498 mL | 0.1872 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tubeimoside II(Tubeimoside-B) is a natural analogue of oleanane type of triterpenoid saponin; show anti-inflammatory, antitumor, and antitumor-promoting effects. IC50 value: Target: The anti-inflammatory, anti-tumor, and anti-tumorigenic activities of tubeimoside II are stronger than those of tubeimoside I, and the acute toxicity of tubeimoside II is lower than that of tubeimoside I; the anti-inflammatory, anti-tumor, and anti-tumorigenic activities of tubeimoside III are stronger than those of tubeimoside II, and the acute toxicity of tubeimoside III is also stronger than that of tubeimoside II.
References:
[1]. Yu TX, et al. Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects. Acta Pharmacol Sin. 2001 May;22(5):463-8.
- ent-Atisane-3beta,16alpha,17-triol
Catalog No.:BCN6626
CAS No.:115783-44-3
- 15,16-Dihydro-15-methoxy-16-oxohardwickiic acid
Catalog No.:BCN1612
CAS No.:115783-35-2
- Galanolactone
Catalog No.:BCN6037
CAS No.:115753-79-2
- 1-O-galloyl-6-O-cinnamoylglucose
Catalog No.:BCN8264
CAS No.:115746-69-5
- 6'-O-beta-D-Glucosylgentiopicroside
Catalog No.:BCN2814
CAS No.:115713-06-9
- Adonifoline
Catalog No.:BCN2056
CAS No.:115712-88-4
- Daidzein dimethyl ether
Catalog No.:BCN6761
CAS No.:1157-39-7
- B2
Catalog No.:BCC7505
CAS No.:115687-05-3
- H-DL-Pro-NH2
Catalog No.:BCC3027
CAS No.:115630-49-4
- Cinnamyl caffeate
Catalog No.:BCN7721
CAS No.:115610-32-7
- Cinnamyl isoferulate
Catalog No.:BCN7718
CAS No.:115610-31-6
- Cinnamyl coumarate
Catalog No.:BCN7739
CAS No.:115610-30-5
- Tubeimoside III
Catalog No.:BCN2956
CAS No.:115810-13-4
- 2,7-Dideacetoxytaxinine J
Catalog No.:BCN7281
CAS No.:115810-14-5
- Salvianolic acid C
Catalog No.:BCN5376
CAS No.:115841-09-3
- Aurora A Inhibitor I
Catalog No.:BCC2182
CAS No.:1158838-45-9
- N1-Methoxymethyl picrinine
Catalog No.:BCN6038
CAS No.:1158845-78-3
- Tos-Arg-OH
Catalog No.:BCC2873
CAS No.:1159-15-5
- Angoroside C
Catalog No.:BCN4997
CAS No.:115909-22-3
- Tarafenacin D-tartrate
Catalog No.:BCC4148
CAS No.:1159101-48-0
- Salvianolic acid B
Catalog No.:BCN6106
CAS No.:115939-25-8
- Alstonic acid A
Catalog No.:BCN6039
CAS No.:1159579-44-8
- Alstonic acid B
Catalog No.:BCN6040
CAS No.:1159579-45-9
- Poricoic acid AE
Catalog No.:BCN7282
CAS No.:1159753-88-4
Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects.[Pubmed:11743898]
Acta Pharmacol Sin. 2001 May;22(5):463-8.
AIM: To study structure-activity relationship of tubeimosides isolated from Bolbostemma paniculatum for their anti-inflammatory, antitumor, and antitumor-promoting effects. METHODS: Tubeimosides I, II, and III were isolated from tubers of Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae), a Chinese folk medicine,"Tubeimu", and their anti-inflammatory, anti-tumor, anti-tumorigenic activities, and acute toxicity were studied in vivo. RESULTS: Tubeimosides I, II, and III are all natural analogues of oleanane type of triterpenoid saponins from the same medicinal plant, and all show anti-inflammatory, antitumor, and antitumor-promo ting effects. However, the anti-inflammatory, anti-tumor, and anti-tumorigenic activities of Tubeimoside II are stronger than those of tubeimoside I, and the acute toxicity of Tubeimoside II is lower than that of tubeimoside I; the anti-inflammatory, anti-tumor, and anti-tumorigenic activities of Tubeimoside III are stronger than those of Tubeimoside II, and the acute toxicity of Tubeimoside III is also stronger than that of Tubeimoside II. CONCLUSION: C-16 hydroxyl group of Tubeimoside II plays an important role in enhancing biological activity of Tubeimoside II and in decreasing its toxicity. The difference of chemical structure in B and/or C position between tubeimosides III and II plays an important role in enhancing biological activity and toxicity of Tubeimoside III. Therefore tubeimosidre II may be the most promising agent for cancer chemoprevention and chemotherapy among tubeimosides I, II, and III.
